Pacific Biosciences of California, Inc. is a biotechnology company that specializes in developing and commercializing innovative sequencing systems to assist in scientific research and genetic analysis. Its flagship technology, the Single Molecule, Real-Time (SMRT) sequencing platform, enables detailed and accurate exploration of genetic structures, making it invaluable to researchers in genomics, epigenetics, and personalized medicine. This technology is pivotal for advancing understanding in various sectors, including agriculture, healthcare, and environmental biology, by providing comprehensive genome sequencing data. With the rise of personalized and precision medicine, Pacific Biosciences' systems play a critical role in mapping complex genetic information, thus assisting healthcare professionals and researchers in developing targeted therapies and diagnostics. The company is positioned at the forefront of the biotechnology market, leveraging its technological prowess to impact scientific and medical advances on a global scale. Pacific Biosciences continues to contribute to pivotal research worldwide, enabling breakthroughs in numerous fields that rely on high-fidelity, long-read sequencing capabilities.
www.pacb.com